Researcher
Pieter Pannus
- Keywords:Medicine
Affiliations
- Medical Genetics (Department)
Member
From1 Oct 2019 → 27 Sep 2020 - Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From19 Sep 2007 → 3 Jul 2009
Publications
1 - 5 of 5
- Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer(2023)
Authors: Yana Debie, Jonas R.M. Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Lise Verbruggen, Greetje Vanhoutte, Elly Marcq, Lisa Verheggen, Debbie Le Blon, et al.
Pages: 635-646 - Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant(2022)
Authors: Kevin K Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken, Kurt Van Lent, Sandra Coppens, Betty Willems, Pieter Pannus, Geert A Martens, Marjan Van Esbroeck, et al.
- Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcription(2020)
Authors: Pieter Pannus, Sofie L. Rutsaert, Stéphane De Wit, Sabine Allard, Guido Vanham, Basiel Cole, Coca Nescoi, Joeri L Aerts, Ward De Spiegelaere, Achilleas Tsoumanis, et al.
- Therapeutic Vaccine in Chronically HIV-1-Infected Patients(2019)
Authors: Wesley de Jong, Lorna Leal, Jozefien Buyze, Pieter Pannus, Alberto C Guardo, Maria Salgado, Beatriz Mothe, Jose Molto, Sara Moron-Lopez, Cristina Gálvez, et al.
- Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection(2018)
Authors: Lorna Leal, Alberto C Guardo, Sara Morón-López, Maria Salgado, Beatriz Mothe, Carlo Heirman, Pieter Pannus, Guido Vanham, Henk-Jan van den Ham, Rob A. Gruters, et al.
Pages: 2533-2545